Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03807635 · ClinicalTrials.gov registry record · NA
Simulated Clinical Use Testing on Safety Lancets (Test A)
A NA study of Needle Stick, sponsored by HTL-Strefa S.A..
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 2
- Study locations
NCT03807635 is a NA study of Needle Stick that has completed, run by HTL-Strefa S.A.. The registered enrollment target is 20 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT03807635, a NA study of Needle Stick, has completed, sponsored by HTL-Strefa S.A..
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 2
- Study locations
Study Summary
A simulated clinical use testing on the HTL-Strefa's safety lancets
Conditions Studied
Interventions
- DEVICE ergoLance safety lancet
- DEVICE Acti-Lance safety lancet
Study Locations (2)
Illinois
- UL LLC - Chicago
Massachusetts
- Schlesinger Associates - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-11-30 |
| Est. Completion | 2018-12-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03807635
The ClinicalTrials.gov registry entry for NCT03807635 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HTL-Strefa S.A., which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Needle Stick appearing as the primary indexed condition, and to 2 interventions - of which ergoLance safety lancet is the first listed.
NCT03807635 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Illinois, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03807635 about?
NCT03807635 is a clinical study titled "Simulated Clinical Use Testing on Safety Lancets (Test A)". A simulated clinical use testing on the HTL-Strefa's safety lancets
What is the current status of trial NCT03807635?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2018-11-30. Estimated completion is 2018-12-13.
What conditions does trial NCT03807635 study?
This clinical trial studies the following conditions: Needle Stick.
What interventions are being tested in trial NCT03807635?
The interventions under investigation include: ergoLance safety lancet (DEVICE), Acti-Lance safety lancet (DEVICE).
Who is sponsoring clinical trial NCT03807635?
This trial is sponsored by HTL-Strefa S.A., which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03807635 being conducted?
This trial has 2 study locations across Illinois, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Needle Stick
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.